Clinical Trials Directory

Trials / Conditions / Locally Advanced Bladder Urothelial Carcinoma

Locally Advanced Bladder Urothelial Carcinoma

9 registered clinical trials studyying Locally Advanced Bladder Urothelial Carcinoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingEnfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bl
NCT06764095
Mayo ClinicPhase 4
Active Not RecruitingTesting Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemo
NCT04963153
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTrying to Find the Correct Length of Treatment With Immune Checkpoint Therapy
NCT04637594
Alliance for Clinical Trials in OncologyPhase 3
Active Not RecruitingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or
NCT04940299
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingARID1A and/or KDM6A Mutation and CXCL13 Expression
NCT04953104
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingImmune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma
NCT04848519
Emory UniversityPhase 2
Active Not RecruitingAtezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metasta
NCT03237780
National Cancer Institute (NCI)Phase 2
Active Not RecruitingTesting MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advance
NCT03244384
National Cancer Institute (NCI)Phase 3
Active Not RecruitingSapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mut
NCT03047213
National Cancer Institute (NCI)Phase 2